Bladder cancer drug ($IBRX) in final FDA approvals just given green light by Saudi equivalent of FDA

I’ve been holding $IBRX (ImmunityBio) for about 5 years now. I originally bought for $5 in 2020 and it ran up to $30 at which point I exited.

I started buying again at about $10 at which point they ran into a snag, but their stud CEO fixed all of that. I’m still a bit down overall but it’s up 29% today and 67% over the past week, still well under the $30 high of 2021. Incredibly promising news coming out currently and I see tons of upside.